Medicines, Poisons and Therapeutic Goods Regulation 2026
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Medicines, Poisons and Therapeutic Goods Regulation 2026
Start here
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
184 Breaching therapeutic standards—the Act, ss 10, 12 and 150(b) and (c)
(1) An authorised practitioner or pharmacist must not supply a scheduled substance in a quantity, or for a purpose, that does not accord with—
(a) the recognised therapeutic standards of what is appropriate in the circumstances, or
(b) the purpose stated on its container, or
(c) the purpose for which it is normally used.
Maximum penalty—Tier 5 penalty.
(2) An authorised practitioner must not issue a prescription for a scheduled substance in a quantity, or for a purpose, that does not accord with—
(a) the recognised therapeutic standards of what is appropriate in the circumstances, or
(b) the purpose stated on its container, or
(c) the purpose for which it is normally used.
Maximum penalty—Tier 5 penalty.
(3) A person authorised under this regulation to administer a scheduled substance must not administer a Schedule 2, 3, 4 or 8 substance in a quantity, or for a purpose, that does not accord with—
(a) the recognised therapeutic standards of what is appropriate in the circumstances, or
(b) the purpose stated on its container, or
(c) the purpose for which it is normally used.
Maximum penalty—Tier 5 penalty.